On Demand Webinars
-
Insights And Strategies For GMP Manufacturing Of RNA-Lipid Nanoparticles
4/25/2024
The emergence of RNA-encapsulated-lipid nanoparticles has introduced a seismic shift in biopharma innovation. But how will the industry adapt to diversifying applications and scales going forward?
-
Plasmid DNA Downstream Purification Process
4/11/2023
Large scale production of plasmid DNA requires an in-depth understanding and optimization of the entire downstream process. Explore a complete solution, from harvest to bulk filtration.
-
Molecular And Colloidal Ionization Properties Of Lipid Nanoparticle mRNA Vaccines
4/13/2022
Dr. Michael Buschmann, George Mason University, presents an overview of molecular and colloidal ionization properties of lipid nanoparticle mRNA vaccines.
-
Quality Roundtable: Optimizing Biologics Manufacturing Processes With Raw Materials
1/24/2024
Improve your commercial manufacturing process with advice from regulatory and raw materials experts on the development journey from pre-clinical to licensure.
-
Train Biomanufacturing Operators Faster And More Effectively With Blended Learning
7/24/2024
Can batch loss be minimized by a new approach to operator training? Learn how blended learning can enhance training effectiveness and engagement, reducing human error in your biopharma production line.
-
RNA Interference - From Single Gene Studies To Whole Genome Screens
11/7/2022
Endoribonuclease-prepared siRNAs (esiRNAs) are able to overcome the limitations of RNAi. Learn about esiRNAs, their advantages over standard siRNAs, and ways this technology is utilized in different research fields.
-
Addressing Industry Challenges In mRNA Product Commercialization
While the speed of production and flexibility of mRNA are appealing, several industry challenges must still be addressed to realize the full potential and further expand its use.
-
How To Value Automation With The Return On Invested Capital Model
6/4/2024
Gain insight into the Return on Invested Capital (ROIC) advantages of an automated manufacturing facility and its correlation to the digital maturity of your operation.
-
Building An Effective CCS For Sterile Filtration
6/20/2023
What are the regulatory expectations for sterile filtration throughout product development, how do these feed into the CSS, and how do end-user and supplier responsibilities support Annex 1 compliance?
-
RNA Vaccine Development To Phase I
4/14/2022
Dr. John Lewis, Founder and CEO, Entos Pharmaceuticals, presents RNA Vaccine Development to Phase I.